Review of endovascular brachytherapy physics for prevention of restenosis.
Intraluminal irradiation of coronary and peripheral arteries has been shown to reduce neointimal hyperplasia following balloon angioplasty, thereby inhibiting restenosis. Several irradiation techniques are being investigated, including temporary intravascular insertion of high activity gamma- or beta-emitting seeds and wires; inflation of dilatation balloon catheter with radioactive liquid or gas; insertion of miniature x-ray tubes via coronary catheters; permanent implantation of radioactive stents; and postangioplasty fractionated external beam irradiation. Unlike conventional brachytherapy, intravascular treatment of restenosis requires accurate knowledge of dose at distances of 0.5-5 mm from the radioactive source. This requirement presents special problems with regard to source calibration and dose specification, because dose gradients at such close distances from a radioactive source are extremely large. This makes it virtually impossible to define the characteristics of an ideal radiation source without some knowledge of the location and radiosensitivity of the target tissues, plus the radiotolerance of normal tissues. Hence, the current debate over whether beta or gamma sources are to be preferred. Imprecise knowledge of dose-volume effects for coronary arteries, plus uncertainties in the biological time sequencing of restenosis fuel a second debate on whether external beam treatments may be efficacious, and whether or not permanent radioactive stents may prove superior to high dose, single fraction brachytherapy. We review here the dosimetric properties of the various irradiation techniques and isotopes that have been proposed, including aspects of radiation safety, dose homogeneity, and practical aspects of source delivery.
Amols
H I
HI
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. amolsh@mskcc.org
D000818:Animals; D055592:Biophysical Phenomena; D001703:Biophysics; D001808:Blood Vessels / Q000473:pathology* / Q000528:radiation effects*; D001918:Brachytherapy / Q000379:methods*; D002404:Catheterization; D003251:Constriction, Pathologic / Q000517:prevention & control / Q000532:radiotherapy / Q000628:therapy; D003327:Coronary Disease / Q000473:pathology / Q000517:prevention & control / Q000532:radiotherapy; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D012008:Recurrence; D015607:Stents
D007496:Iridium Radioisotopes